NCT06870396View on ClinicalTrials.gov

National Study of Adrenal Tumours

Enrolling by invitationOBSERVATIONAL

Enrollment

300

Participants

Timeline

Start Date

January 15, 2025

Primary Completion Date

June 30, 2034

Study Completion Date

December 31, 2034

Conditions

Pheochromocytoma and Paraganglioma (PPGL)Adrenocorticol Cancer (ACC)Adrenal Tumours

Trial Locations (1)

Unknown

Cambridge NHS, Cambridge

All Listed Sponsors

lead

Society for Endocrinology

OTHER